Activity of Cabozantinib in Patients With Metastatic GIST After Treatment With Imatinib and Sunitinib
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Activity and Safety of the Multi-Target Tyrosine Kinase Inhibitor Cabozantinib in Patients With Metastatic Gastrointestinal Stromal Tumour After Treatment With Imatinib and Sunitinib: European Organisation for Research and Treatment of Cancer Phase II Trial 1317 'CaboGIST'
Eur. J. Cancer 2020 May 26;134(xx)62-74, P Schöffski, O Mir, B Kasper, Z Papai, JY Blay, A Italiano, C Benson, K Kopeckova, N Ali, P Dileo, A LeCesne, F Menge, S Cousin, E Wardelmann, A Wozniak, S Marreaud, S Litiere, F Zaffaroni, A Nzokirantevye, I Vanden Bempt, H GelderblomFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.